FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

396411005: Toxoid (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1764328019 Toxoid (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1776349017 Toxoid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    25821000077119 anatoxine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    anatoxine Is a Drug, medicament or biological substance false Inferred relationship Some
    anatoxine Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. false Inferred relationship Some
    anatoxine Is a vaccin false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    anatoxine tétanique Is a False anatoxine Inferred relationship Some
    anatoxine diphtérique Is a False anatoxine Inferred relationship Some
    Clostridium haemolyticum - novyi - perfringens types C & D bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - novyi - sordellii - perfringens types C & D - moraxella bovis bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens type C antitoxin - escherichia coli antiserum The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens type D antitoxin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bordetella bronchiseptica - clostridium perfringens type C - erysipelothrix rhusiopathiae - escherichia coli - pasteurella multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens types C & D toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Pasteurella haemolytica toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bordetella bronchiseptica - erysipelothrix rhusiopathiae - pasteurella multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - novyi - sordellii bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Borrelia burgdorferi bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens type D bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens type C bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Salmonella typhimurium bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Transmissible gastroenteritis immunity inducer The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    C & D bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Mycobacterium cell wall immunostimulant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Transmissible gastroenteritis vaccine - clostridium perfringens type C - escherichia coli bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens types C & D tetanus toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens type C antitoxin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Staphylococcus aureus phage lysate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Flea antigen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium haemolyticum - novyi bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Antitoxin (animal) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens types C & D bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - novyi - sordellii - pasteurella haemolytica - multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - novyi - sordellii - perfringens types C & D bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens type C toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - sordellii - perfringens types The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Toxoid (animal) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - novyi - sordellii - perfringens types C & D - haemophilus somnus bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - novyi - sordellii haemophilus somnus bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Toxin (animal) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bordetella bronchiseptica - escherichia coli - pasteurella multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii - leptospira pomona bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - haemolyticum - novyi - tetani - perfringens types C & D bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Mycobacterium cell wall fraction immunostimulant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii - perfringens types C & D - leptospira pomona - pasteurella haemolytica - multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Staphylococcus aureus bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium botulinum type C bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens types C & D - escherichia coli bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Pasteurella multocida toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens type C - erysipelothrix rhusiopathiae - escherichia coli bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - sordellii bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bordetella bronchiseptica - pasteurella multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Erysipelothrix rhusiopathiae - pasteurella multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium botulinum type B toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Autogenous bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Aeromonas salmonicida bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - novyi bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii - pasteurella haemolytica - multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bordetella bronchiseptica - erysipelothrix rhusiopathiae - haemophilus parasuis - pasteurella multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens types C & D antitoxin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - sordellii - pasteurella haemolytica - multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bordetella bronchiseptica - clostridium perfringens type C - escherichia coli bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Propionibacterium acnes immunostimulant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii - perfringens types C & D bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium novyi bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens type C escherichia coli bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Clostridium perfringens type D toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bordetella bronchiseptica - clostridium perfringens type C - escherichia coli - pasteurella multocida bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Escherichia coli bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Botulinum toxoid (substance) Is a False anatoxine Inferred relationship Some
    Heptavalent equine antitoxin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Trivalent equine antitoxin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Diphtheria vaccine Is a False anatoxine Inferred relationship Some
    Parvovirus - pseudorabies vaccine - erysipelothrix rhusiopathiae - leptospira bratislava - canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bovine rhinotracheitis - parainfluenza 3 vaccine - haemophilus somnus bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Parvovirus vaccine - erysipelothrix rhusiopathiae - leptospira bratislava canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Corynebacterium pyogenes - pasteurella haemolytica - multocida antiserum The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bordetella bronchiseptica vaccine - erysipelothrix rhusiopathiae - pasteurella multocida bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Parvovirus vaccine - erysipelothrix rhusiopathiae - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona - pasteurella multocida bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Parvovirus - pseudorabies vaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Parvovirus vaccine - leptospira bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 - respiratory syncytial virus vaccine - pasteurella haemolytica bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Parvovirus vaccine - erysipelothrix rhusiopathiae - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Corynebacterium pyogenes - escherichia coli - pasteurella multocida - salmonella typhimurium antiserum The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Transmissible gastroenteritis vaccine - clostridium perfringens type C bacterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Parvovirus - pseudorabies vaccine - erysipelothrix rhusiopathiae - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Corynebacterium pyogenes - pasteurella multocida antiserum The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Bovine virus diarrhea vaccine/leptospira canicola/grippotyphosa/hardjo/icterohemorrhagiae/pomona bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some
    Product containing toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some 1
    Pentavalent botulinum toxoid vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anatoxine Inferred relationship Some 1

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start